908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.
BörsenkürzelMASS
Name des Unternehmens908 Devices Inc
IPO-datumDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
Anzahl der mitarbeiter246
WertpapierartOrdinary Share
GeschäftsjahresendeDec 18
Addresse645 Summer Street
StadtBOSTON
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl02210
Telefon19787294478
Websitehttps://908devices.com/
BörsenkürzelMASS
IPO-datumDec 18, 2020
CEODr. Kevin J. Knopp, Ph.D.
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten